We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+12.09%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$683M
AUM Growth
-$101M
Cap. Flow
-$82.5M
Cap. Flow %
-12.08%
Top 10 Hldgs %
52.33%
Holding
153
New
26
Increased
35
Reduced
53
Closed
35

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$20M
2
BIIB icon
Biogen
BIIB
+$11.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.32M
4
ORA icon
Ormat Technologies
ORA
+$5.09M
5
OPK icon
Opko Health
OPK
+$5.01M

Top Sells

Rank Stock Value
1
ESLT icon
Elbit Systems
ESLT
+$29.2M
2
SHPG
Shire pic
SHPG
+$27M
3
AGN
Allergan plc
AGN
+$23M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$12.7M
5
VTRS icon
Viatris
VTRS
+$9.62M

Sector Composition

Rank Sector Weight
1 Healthcare 60.65%
2 Utilities 5.79%
3 Technology 1.86%
4 Consumer Discretionary 1.38%
5 Communication Services 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHKP icon
26
Check Point Software Technologies
CHKP
$13B
$4.55M 0.67%
55,857
-16,470
-23% -$1.37M
PTLA
27
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.4M 0.64%
85,500
-9,500
-10% -$461K
MRNS
28
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$4.36M 0.64%
142,727
+102,197
+252% +$3M
RDUS
29
DELISTED
Radius Health, Inc.
RDUS
$4.31M 0.63%
+70,000
New +$4.42M
VNDA icon
30
Vanda Pharmaceuticals
VNDA
$307M
$4.3M 0.63%
462,051
-51,339
-10% -$512K
ADMS
31
DELISTED
Adamas Pharmaceuticals
ADMS
$4.25M 0.62%
+150,000
New +$2.53M
RCKT icon
32
Rocket Pharmaceuticals
RCKT
$340M
$4.08M 0.6%
90,000
+16,250
+22% +$708K
ALNY icon
33
Alnylam Pharmaceuticals
ALNY
$27.5B
$3.77M 0.55%
40,000
– –
ALDR
34
DELISTED
Alder Biopharmaceuticals
ALDR
$3.72M 0.54%
112,500
-12,500
-10% -$423K
ORBK
35
DELISTED
Orbotech Ltd
ORBK
$3.71M 0.54%
167,619
+89,137
+114% +$1.67M
ZVRA icon
36
Zevra Therapeutics
ZVRA
$562M
$3.65M 0.53%
11,497
-1,278
-10% -$347K
HRTX icon
37
Heron Therapeutics
HRTX
$93.9M
$3.6M 0.53%
135,000
+85,000
+170% +$2.27M
GOOG icon
38
CALL
Alphabet (Google) Class C
GOOG
$4.36T
$3.58M 0.52%
+92,000
New +$3.3M
ACAD icon
39
Acadia Pharmaceuticals
ACAD
$4.43B
$3.56M 0.52%
+100,000
New +$3.52M
CPRX
40
DELISTED
Catalyst Pharmaceutical
CPRX
$3.56M 0.52%
1,455,000
+355,000
+32% +$1.02M
RPTP
41
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$3.56M 0.52%
685,000
+100,911
+17% +$586K
GWPH
42
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.47M 0.51%
+50,000
New +$4.07M
BHC icon
43
Bausch Health
BHC
$2.58B
$3.43M 0.5%
33,750
+18,000
+114% +$2.02M
CNCE
44
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3.42M 0.5%
180,000
-20,000
-10% -$435K
TJX icon
45
TJX Companies
TJX
$174B
$3.4M 0.5%
95,922
+12,930
+16% +$460K
ANAC
46
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$3.39M 0.5%
30,000
+20,000
+200% +$2.2M
KDNY
47
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3.38M 0.49%
+24,000
New +$3.26M
NVAX icon
48
Novavax
NVAX
$1.2B
$3.36M 0.49%
20,000
+12,500
+167% +$1.92M
TVRD
49
Tvardi Therapeutics
TVRD
$19.7M
$3.33M 0.49%
5,495
-611
-10% -$335K
CLVS
50
DELISTED
Clovis Oncology, Inc.
CLVS
$3.31M 0.48%
94,500
-10,500
-10% -$677K
1
2
3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sphera Funds Management held 153 positions worth $683M, down 13% from $784M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sphera Funds Management withdrew a net $82.5M in Q4 2015, closing 35 positions and reducing 53 holdings. Its most notable exit was Elbit Systems, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 56% a quarter earlier, followed by Utilities and Technology.

Against the trend, Sphera Funds Management opened a new position in Alphabet (Google) Class C worth $5.76M.

  • Sphera Funds Management's largest Q4 2015 buy was Alphabet (Google) Class C: 148,180 shares worth $5.76M.
  • Sphera Funds Management added most to Pfizer in Q4 2015, an estimated $20M increase.
  • Sphera Funds Management's biggest Q4 2015 reduction was Shire pic, cutting an estimated $27M.
  • Sphera Funds Management fully exited Elbit Systems in Q4 2015, selling an estimated $29.2M.
  • Sphera Funds Management's ten largest holdings make up 52% of its $683M portfolio in Q4 2015.
  • Sphera Funds Management opened 26 new positions and closed 35 in Q4 2015.
  • Sphera Funds Management's portfolio value fell 13% quarter-over-quarter to $683M.

Based on Sphera Funds Management's 13F filing for Q4 2015, filed 11 Feb 2016.